Coronavirus disease (COVID-19) in hepatic patients
Abd El Hamed, R., Galal, G., Ahmed, N., Abd-El-Fatah, M., abd el rhman, M. (2020). Coronavirus disease (COVID-19) in hepatic patients. EKB Journal Management System, 24(2), 40-45. doi: 10.21608/smj.2020.28077.1145
Reem Mahmoud Abd El Hamed; Ghada Moustafa Galal; Nagwa Sayed Ahmed; Mahmoud Saif-Al-Islam Abd-El-Fatah; mona mohammed abd el rhman. "Coronavirus disease (COVID-19) in hepatic patients". EKB Journal Management System, 24, 2, 2020, 40-45. doi: 10.21608/smj.2020.28077.1145
Abd El Hamed, R., Galal, G., Ahmed, N., Abd-El-Fatah, M., abd el rhman, M. (2020). 'Coronavirus disease (COVID-19) in hepatic patients', EKB Journal Management System, 24(2), pp. 40-45. doi: 10.21608/smj.2020.28077.1145
Abd El Hamed, R., Galal, G., Ahmed, N., Abd-El-Fatah, M., abd el rhman, M. Coronavirus disease (COVID-19) in hepatic patients. EKB Journal Management System, 2020; 24(2): 40-45. doi: 10.21608/smj.2020.28077.1145

Coronavirus disease (COVID-19) in hepatic patients

Sohag Medical Journal
Article 7, Volume 24, Issue 2, April 2020, Page 40-45  XML PDF (258.52 K)
Document Type: Original Article
DOI: 10.21608/smj.2020.28077.1145
View on SCiNiTO View on SCiNiTO
Authors
Reem Mahmoud Abd El Hamed email 1; Ghada Moustafa Galal2; Nagwa Sayed Ahmed3; Mahmoud Saif-Al-Islam Abd-El-Fatahorcid 4; mona mohammed abd el rhman5
1tropical medicine, faculty of medicine, sohag university, sohag, egypt
2Department of Tropical Medicine and Gastroenterology, Faculty of Medicine, Sohag University.
3Medical Biochemistry, Faculty of Medicine, Sohag University
4Department of Tropical Medicine and Gastroenterology, Faculty of Medicine, Sohag University
5tropical medicine and gastroentrology, faculty of medicine, sohag university
Abstract
Abstract
A new coronavirus (severe acute respiratory syndrome) (SARS-CoV-2) epidemic initially began in Wuhan, China, in December 2019, which became an international harm to public life. Globally the count of reported patients of COVID-19 (SARS-CoV-2) from 31st December 2019 to 14th April 2020 has achieved 1 873 265 cases, which include 118 854 fatalities. Many of the COVID-19 cases seem to be mild and rapidly improved, however, the infection can be terminal, with an incidence of deaths about 3 percent. Pulmonary disease was found to be the main injury done via the coronavirus two disease (SARS-CoV-2). Furthermore, hepatic damage was documented to exist in extremely ill patients. Likewise, multiple pieces of research found that hepatic injury became widespread in cases diagnosed with another two more serious coronavirus, severe acute respiratory syndrome coronavirus (SARS-CoV) and the Middle East respiratory syndrome coronavirus (MERS-CoV) and correlated to the intensity and poor outcome of the infection.
Keywords
Keywords: COVID-19; Chronic liver disease; Management
Statistics
Article View: 436
PDF Download: 459